D. Hellenbrecht

Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine ?-adrenergic blocking agents

D. Hellenbrecht, Björn Lemmer, G. Wiethold et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1973 · 148 citations

Quantitative Parameters, -Adrenergic Blocking Agents, Medicine +12

Human blood platelets as cellular models for investigation of membrane active drugs: Beta-adrenergic blocking agents

Björn Lemmer, G. Wiethold, D. Hellenbrecht et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1972 · 43 citations

Thrombopoiesis, Thrombosis, Blood Platelet +12

Membrane effects of beta-adrenergic blocking agents: Investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities

G. Wiethold, D. Hellenbrecht, Björn Lemmer et al. · Biochemical Pharmacology · 1973 · 32 citations

Membrane Effects, Biochemistry, Medicine +7

Inhibition by antiarrhythmic and ?-sympatholytic drugs of serotonin uptake by human platelets: Experimentsin vitro andin vivo

H. Grobecker, Björn Lemmer, D. Hellenbrecht et al. · European Journal of Clinical Pharmacology · 1973 · 25 citations

Thrombosis, Human Platelets, Serotonin Uptake +9

Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.

Reinhard Saller, D. Hellenbrecht · PubMed · 1985 · 25 citations

Cisplatin Administration, Pharmacological Study, Cisplatin-induced Emesis +12